Top Story

Roswell Park Cancer institute appoints vice chair for translational research

April 30, 2017

Pawel Kalinski, MD, PhD, has been appointed vice chair for translational research at Roswell Park Cancer Institute.

Kalinski also will serve as director of cancer vaccine and dendritic cell therapies within the institute’s Center for Immunotherapy, as well as professor for molecular therapeutics and translational research, professor of oncology, and co-leader of the tumor immunology and immunotherapy program.

Meeting News

Nivolumab shows promise for advanced liver cancer

April 28, 2017
Nivolumab appeared safe and effective in patients with advanced liver cancer who did not respond to sorafenib, according to results from the CheckMate 040 study…
FDA News

FDA grants accelerated approval to brigatinib for ALK–positive NSCLC

April 28, 2017
The FDA granted accelerated approval to brigatinib for the treatment of patients with metastatic anaplastic lymphoma kinase–positive non–small cell lung…
In the Journals

Pigmented lesion assay improves biopsy specificity in diagnosing melanoma

April 28, 2017
The use of a noninvasive pigmented lesion assay significantly improved biopsy specifity, which may allow dermatologists to miss fewer melanomas while reducing the number…
In the Journals Plus

Low-, high-dose radioiodine comparable for thyroid remnant ablation success

April 28, 2017
Chinese adults with differentiated thyroid carcinoma can be effectively treated with low doses of radioiodine for thyroid remnant ablation, according to published…
More News Headlines »

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Meeting News

VIDEO: Key takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

April 20, 2017
More »
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting


The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today